The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
IMpower132: A phase III clinical program—1L atezolizumab plus platinum-based chemotherapy in chemo-naive advanced non-squamous NSCLC.
 
Howard Jack West
Consulting or Advisory Role - ARIAD; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Guardant Health; Merck; Novartis
Speakers' Bureau - ARIAD; Genentech/Roche
 
Makoto Nishio
Honoraria - AstraZeneca; Bristol-Myers Squibb Japan; Chugai Pharma; Lilly Japan; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical
Consulting or Advisory Role - Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Lilly Japan; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Chugai Pharma (Inst); Lilly (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst)
 
Manuel Cobo Dols
No Relationships to Disclose
 
Haruhiro Saito
No Relationships to Disclose
 
Michael Howland
Employment - Genentech/Roche
Stock and Other Ownership Interests - Aduro Biotech; Aduro Biotech; Amgen; Illumina; Juno Therapeutics; Medivation; Merck; Roche/Genentech
 
Tien Hoang
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
 
Takashi Asakawa
Employment - Genentech
 
Alan Sandler
Employment - Genentech
Stock and Other Ownership Interests - Genentech/Roche
 
Mark A. Socinski
Honoraria - Genentech
Consulting or Advisory Role - Genentech
Research Funding - Pfizer (Inst)